07.27.15
Gnosis, Desio, Italy, was a proud partner of the FASEB (Federation of American Societies for Experimental Biology) Conference on Vitamin K - Molecular, Structural & Clinical Aspects of Vitamin K and Vitamin K-Dependent Proteins, held on July 13 in Itasca, IL.
The company stated that this conference provided opportunities to discuss in depth research, scientific updates and new directions for future applications with vitamin K. Key areas of discussion included:
· Emerging aspects of vitamin K biochemistry such as metabolic and anti-inflammatory roles
· Current research on vitamin K metabolism and its unique actions both from basic and clinical research perspectives
· New developments in emerging roles for vitamin K-dependent proteins in managing clinical conditions such as CVD, osteoarthritis, and chronic kidney disease
Clinicians, epidemiologists, basic and nutrition scientists and governmental policy makers provided a forum for the exchange of new knowledge about vitamin K that spanned from basic research to a wide variety of clinical applications to facilitate new collaborations and areas of novel research.
Gnosis is one of the main producers of vitamin K2 as menaquinone-7 branded as VitaMK7 and has more than 10 years of manufacturing experience.
The company stated that this conference provided opportunities to discuss in depth research, scientific updates and new directions for future applications with vitamin K. Key areas of discussion included:
· Emerging aspects of vitamin K biochemistry such as metabolic and anti-inflammatory roles
· Current research on vitamin K metabolism and its unique actions both from basic and clinical research perspectives
· New developments in emerging roles for vitamin K-dependent proteins in managing clinical conditions such as CVD, osteoarthritis, and chronic kidney disease
Clinicians, epidemiologists, basic and nutrition scientists and governmental policy makers provided a forum for the exchange of new knowledge about vitamin K that spanned from basic research to a wide variety of clinical applications to facilitate new collaborations and areas of novel research.
Gnosis is one of the main producers of vitamin K2 as menaquinone-7 branded as VitaMK7 and has more than 10 years of manufacturing experience.